Pharming announces results from clinical trials for the treatment of COVID-19 with RUCONEST
FirstWord Pharma,
Pharming-sponsored study in US met primary endpoint RUCONEST®-treated patients having statistically significant lower disease…
Pharming-sponsored study in US met primary endpoint RUCONEST®-treated patients having statistically significant lower disease…
H1 PR 2021 Pharming announces results from clinical trials for the treatment of COVID-19 with RUCONEST® Pharming-sponsored…
By: PR Newswire Association LLC. - 14 Sep 2021 Pharming-sponsored study in US met primary endpoint RUCONEST®-treated patients…
Pharming-sponsored study in US met primary endpoint RUCONEST®-treated patients having statistically significant lower disease…
Pharming-sponsored study in US met primary endpoint RUCONEST®-treated patients having statistically significant lower disease…
In this article: Pharming-sponsored study in US met primary endpoint RUCONEST®-treated patients having statistically…
Pharming-sponsored study in US met primary endpoint RUCONEST®-treated patients having statistically significant lower disease…